Grünenthal: latest news - GoINPHARMA
Tuesday, 26 March 2019 - 13:35


An analysis of German group Grünenthal

The German daily Frankfurter Allgemeine Zeitung has published a long article about the Germany-based drugmaker Grünenthal. Grünenthal is one of the last family-owned large firms, although its owners a decade ago decided to leave its helm to an external manager….

Grünenthal acquires Thar Pharmaceuticals

Grünenthal announced it acquired US-based Thar Pharmaceuticals, headquartered in Pittsburgh (SA), developing solutions for pain treatment. The leading product in Thar’s portfolio is probably T121, an oral formulation of zoledronic acid administered intravenously, a candidate targeting Complex Regional Pain Syndrome…